Trial
NCT02100007
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
MEI Pharma, Inc.
Collaborators
SCRI Development Innovations, LLC
Condition
Solid Tumors
Intervention
ME-344
Why stopped
lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-02